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a b s t r a c t 
Background: First-degree relatives of people with dementia (FH + ) are at increased risk of developing Alzheimer’s 
disease (AD). Here, we investigate “estimated years to onset of dementia ” (EYO) as a surrogate marker of pre- 
clinical disease progression and assess its associations with multi-modal neuroimaging biomarkers. 
Methods: 89 FH + participants in the PREVENT-Dementia study underwent longitudinal MR imaging over 2 years. 
EYO was calculated as the difference between the parental age of dementia diagnosis and the current age of the 
participant (mean EYO = 23.9 years). MPRAGE, ASL and DWI data were processed using Freesurfer, FSL-BASIL 
and DTI-TK. White matter lesion maps were segmented from FLAIR scans. The SPM Sandwich Estimator Toolbox 
was used to test for the main effects of EYO and interactions between EYO, Time, and APOE- 𝜀 4 + . Threshold free 
cluster enhancement and family wise error rate correction (TFCE FWER ) was performed on voxelwise statistical 
maps. 
Results: There were no significant effects of EYO on regional grey matter atrophy or white matter hyperintensities. 
However, a shorter EYO was associated with lower white matter Fractional Anisotropy and elevated Mean/Radial 
Diffusivity, particularly in the corpus callosum (TFCE FWER p < 0.05). The influence of EYO on white matter deficits 
were significantly stronger compared to that of normal ageing. APOE- 𝜀 4 carriers exhibited hyperperfusion with 
nearer proximity to estimated onset in temporo-parietal regions. There were no interactions between EYO and 
time, suggesting that EYO was not associated with accelerated imaging changes in this sample. 
Conclusions: Amongst cognitively normal midlife adults with a family history of dementia, a shorter hypothet- 
ical proximity to dementia onset may be associated with incipient brain abnormalities, characterised by white 
matter disruptions and perfusion abnormalities, particularly amongst APOE- 𝜀 4 carriers. Our findings also confer 
biological validity to the construct of EYO as a potential stage marker of preclinical progression in the context 


















It is now established from clinicopathological and in vivo imaging
tudies that the neuropathological process of Alzheimer’s disease (AD)
nd dementia begins decades before the earliest manifestation of cog-
itive or behavioural symptoms ( Ritchie et al., 2016 ). A greater under-∗ Corresponding author. 
E-mail address: fkm24@medschl.cam.ac.uk (E. Mak). 
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dentify novel biomarkers, aid earlier detection and assist in establishing
reatment targets for AD. One approach to delineate early alterations is
o evaluate longitudinal in vivo neuroimaging markers in asymptomatic
ndividuals who are at increased risk for developing dementia. 
Parental family history of dementia (FH + ) is a recognised risk factor
inked with increased cumulative lifetime risk for dementia, earlier age
f onset as well as cognitive impairment ( Scarabino et al., 2016 ). Pre-
ious neuroimaging studies have hinted at the presence of brain abnor-uary 2021 
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f  alities in FH + individuals, such as reduced functional connectivity, hy-
operfusion and grey matter atrophy ( Adluru et al., 2014 ; Honea et al.,
010 ). However, our systematic reviews of structural and functional
maging studies in preclinical dementia have highlighted numerous dis-
ordant findings in the literature ( Habib et al., 2017 ; Mak et al., 2017 ).
ethodological differences, study designs and different age ranges are
ll plausible explanations for the discrepancy of findings in the FH lit-
rature. Yet an alternative possibility is that the presence of brain ab-
ormalities may only be reliably detected amongst individuals who are
n the precipice of symptom onset. Indeed, studies in cohorts of per-
ons with familial AD mutations have proposed the estimated years to
nset (EYO) as a stage marker of preclinical severity ( Bateman et al.,
012 ). By exploiting the near certainty of dementia onset in carriers of
amilial AD mutations, EYO has been derived based on the difference
etween an individual’s age and the parental age of symptom onset.
ts association with deficits in functional connectivity ( Ringman et al.,
011 ), alterations in white matter tracts ( Ringman et al., 2007 ), white
atter lesions ( Viqar et al., 2015 ) and grey matter atrophy ( Cash et al.,
013 ) has been investigated. A brief summary of key imaging findings
n familial AD mutation carriers in relation to EYO is shown in Supple-
entary Table 1. 
Data from the Swedish Twin Registry has demonstrated a strong her-
table component of AD for both men and women ( Gatz et al., 2006 ;
edersen et al., 2004 ). A previous study also showed that heritable
actors were associated with intergenerational age of symptom onset
 Day et al., 2019 ). Collectively, these lines of evidence imply that EYO
ay be generalizable to some extent in sporadic AD and thus represents
 surrogate index of preclinical disease progression. Our group first ex-
rapolated the construct of EYO to a longitudinal cohort of cognitively
ormal midlife adults and found that FH + individuals with a shorter
YO had worse visual working memory scores ( Ritchie et al., 2017 ). Re-
ent reports from an ‘at risk’ cohort have revealed that EYO was associ-
ted with temporo-parietal brain atrophy ( Vogel et al. , 2018 ) and lower
evels of cerebrospinal fluid (CSF) A 𝛽1-42, particularly amongst APOE-
 4 carriers ( Villeneuve et al., 2018 ). Nevertheless, the mean age of their
ohort was 63 years, and consequently the mean EYO was shorter (11
ears to onset) relative to our sample in the PREVENT-Dementia study
 Ritchie et al., 2013 , 2017 ). 
To extend previous cross-sectional studies ( Caballero et al., 2018 ;
illeneuve et al., 2018 ; Vogel et al., 2018 ) and address the current gaps
n our understanding of brain changes occurring during the preclini-
al stages, we mapped out an in-depth characterisation of EYO-related
hanges in (1) grey matter, (2) white matter microstructure, (3) white
atter lesions, and (4) cerebral perfusion in a longitudinal cohort of
H + individuals (mean follow-up of 2 years). We tested the hypotheses
hat individuals approaching their parental age of dementia diagnosis
ould show more severe deficits on multi-modal neuroimaging mea-
ures, expressed by a lower FA, higher MD and RD, more severe burden
f white matter lesions, cortical and hippocampal atrophy, as well as
educed cerebral perfusion. 
. Materials and methods 
.1. Participants and clinical data 
The protocol for the PREVENT study has been described in detail
reviously ( Ritchie and Ritchie, 2012 ). Participants aged 40 to 59 years
ld with or without a parent with dementia were recruited through mul-
iple sources, such as the register database held at West London Mental
ealth National Health Service Trust, part of the UK National Health Ser-
ice. Other participants were recruited via the Join Dementia Research
ebsite through information about the study on the Internet and pub-
ic presentations. Consented participants were seen at the West London
ognitive Disorders Treatment and Research Unit, West London Men-
al Health NHS Trust, where they were given a standardised neuropsy-
hiatric interview and life-style questionnaires. Cognitive assessments2 ere performed with the Addenbrooke’s Cognitive Examination (ACE-
II) during the follow-up visit. Blood was taken for APOE- 𝜀 4 genotyp-
ng with all members of the research and clinical teams remaining blind
o the results. 
.2. Ethics statement 
Approval for the study has been given by the NHS Research Ethics
ommittee London Camberwell St-Giles. EYO was estimated as the dif-
erence between the age of the participant and the age of dementia
iagnosis of the earliest affected parent (if more than one parent had
ementia) ( Ritchie et al., 2017 ). Global cognition and domain-specific
ognition was also evaluated using the Addenbrooke’s Cognitive Exam-
nation (ACE-III) at Visit 2. 
.3. Multi-modal imaging acquisition 
All subjects were scanned using a 3T Siemens Verio scanner. The fol-
owing MR scans were acquired: A 3D T1-weighted magnetization pre-
ared rapid gradient-echo (MPRAGE) image (TR = 2.3 s, TE = 2.98 ms,
60 slices, flip angle = 9 o , voxel size = 1 mm 3 isotropic); a diffusion
eighted image (DWI) with 64 directions ( b = 1000 s/mm 2 ) in addition
o a single non-diffusion weighted volume (TR = 11.7 s, TE = 90 ms, 63
lices, voxel size = 2 × 2 × 2 mm, flip angle = 90°); a Fluid-attenuated
nversion recovery (FLAIR) scan (TR = 9 s; TE = 94 ms, 27 slices, voxel
ize = 0.4 × 0.4 × 4 mm, TI = 2500 ms; flip angle = 150°) and an arte-
ial spin labelling (ASL) dataset (PICORE Q2TIPS, 50 pairs of control/
ag images, one calibration image, TR = 2.5 s / TE = 11 ms, inversion
ime = 1.8 s, bolus duration = 700 ms, voxel size 3.0 × 3.0 × 6.0 mm,
4 slices, flip angle = 90 o ). Details about the number of utilised scans
er modality can be found in Supplementary Fig. 1. 
.4. Image preprocessing 
.4.1. Cortical thickness 
The T1-MPRAGE scans were analysed using the
utomated longitudinal stream of Freesurfer version
.0 ( http://surfer.nmr.mgh.harvard.edu/ ) pipeline. The full details
ave been previously described ( Reuter et al., 2012 , 2010 ). Briefly, the
ipeline applies motion correction, skull stripping, correction for field
nhomogeneities, registration to and from the Talairach coordinate
pace, cortical parcellation and subcortical structure segmentation
 Fischl, 2012 ). Three subjects were excluded due to failure of pre-
rocessing steps of the Freesurfer recon-all pipeline (i.e. excessive
isclassification of pial and white matter surfaces or severe skull
tripping errors). 
.4.2. MNI normalisation 
The individual T1-MPRAGE images were segmented with SPM12 to
enerate grey matter, white matter and CSF tissue probability maps.
he generated grey matter images were inspected and when necessary
anually corrected when parts of dura or residual skull were erro-
eously included in the grey matter cluster. Subsequently, the DARTEL
ipeline was used to create a study specific template based on the grey
nd white matter masks from both study time-points. DARTEL makes
se of non-linear diffeomorphic registration to register individual grey
atter masks to the study-specific template and subsequently an affine
egistration to register the study specific template to the MNI space
 Ashburner, 2007 ). The derived flow fields were used in the subsequent
nalyses to spatially normalise the T1 MRI to the MNI space. The grey
atter mask for subsequent analyses was derived from the average grey
atter maps and thresholded at 25% probability. 
.4.3. Perfusion measures 
ASL post-processing was performed using FSL’s Bayesian Inference
or ASL MRI (BASIL) toolbox ( Chappell et al., 2009 ). The acquired ASL































































































































E  cans were motion corrected using FSL’s MCFLIRT and calibrated based
n a proton density acquisition. Spatial regularization was applied prior
o cerebral blood flow (CBF) calculation. CBF was quantified using the
uxton ASL kinetic model ( Buxton et al., 1998 ) according to the model
uggested in the ASL white paper ( Alsop et al., 2015 ). The generated CBF
mages were corrected for the presence of partial volume effects using
SL BASIL’s adaptive spatial prior approach ( Chappell et al., 2011 ). To
roceed to partial volume correction (PVC), the MPRAGE images were
egistered to the ASL calibration scan using FSL’s FLIRT. The same trans-
ormation was applied to coregister the high-resolution partial volume
aps to the ASL resolution. PVC grey matter perfusion maps and grey
atter CBF mean values were recorded for voxels with grey matter >
0%. Subsequently, the grey matter CBF maps were registered to the T1
mages using the inverse transform generated in the previous step and
ormalized to the MNI space using SPM’s DARTEL. To proceed to voxel-
ise comparisons a grey matter CBF mask was created for each subject
ncluding voxels with at least 5 ml/100 g/min. All individual masks
ere summed up and a threshold of 95% was used for voxel retention.
inally, this mask was multiplied by the grey matter mask generated in
he previous step. Consistent with previous methodology ( Dolui et al.,
017 ), the temporal SNR (tSNR) of the ASL acquisition was determined
s follows: the time-series were motion corrected using FSL MCFLIRT.
ubsequently, individual perfusion weighted images (control-labelled)
ere generated for all 50 repetitions. A mean value for each of the 50
erfusion weighted images within areas of grey matter > 10% was calcu-
ated, and tSNR was measured as the mean over the standard deviation
f these values (2.11 ± 0.9). 
.4.4. White matter microstructure 
The diffusion datasets were visually inspected for optimal coverage
nd to ensure minimal eddy-current distortions by 2 authors (EM and
MK). 9 subjects were excluded due to excessive EPI distortions, while 1
ubject was excluded due to poor field-of-view coverage. DWI data were
tripped of nonbrain tissue using the Brain Extraction Tool (BET). Eddy
urrents and head movements were corrected with “eddy ” in FSL (Ver-
ion 6.0.1). Quantitative identification of slices with signal loss was per-
ormed in “eddy ” and these volumes were replaced by non-parametric
redictions using the Gaussian process ( Andersson et al., 2016 ). In ad-
ition, we also corrected for intra-volume movement ( Andersson et al.,
017 ). The b-matrix was subsequently reoriented by applying the ro-
ational part of the affine transformation used during eddy correction
 Leemans and Jones, 2009 ). Diffusion tensors were generated from the
ddy-corrected DWI datasets using DTIFIT in FSL 6.0.1. We pursued an
nbiased longitudinal approach for the spatial normalisation of diffusion
atasets using the Diffusion Tensor Imaging Toolkit (DTI-TK). Firstly,
ensor images at baseline and follow-up were created by converting the
iffusion eigenvectors and eigenvalues using the function fsl_to_dtitk in
TI-TK. Secondly, for each participant, an unbiased intra-subject tem-
late was generated using the tensor datasets from his or her baseline
nd follow-up after an iterative process of rigid, affine and non-linear
iffeomorphic registrations. Next, the within-subject templates were
sed to create a study-specific population template using the same iter-
tive process. Each participant’s DWI data was normalised to the group-
pecific template via a single interpolation step. Fractional anisotropy
FA), mean diffusivity (MD) and radial diffusivity (RD) maps were gen-
rated using the normalised tensor images. Following the tensor-based
egistration, a mean FA map was derived from the group template and
keletonised using tbss_skeleton in FSL to create the mean FA skeleton
thresholded at FA > 0.2). FA, MD and RD images from each participant
ere projected onto the mean FA skeleton by searching for maximum
A values perpendicular to the skeleton. To complement our voxel-wise
nalyses, mean global FA, RD and MD values were extracted at baseline
nd follow-up from each participant’s white matter skeleton using the
slmaths command. 3 .4.5. Quantification of WMH 
WMH lesion maps were obtained using an automated
cript on the Statistical Parametric Mapping 8 (SPM8) suite
 http://www.fil.ion.ucl.ac.uk/spm/ ) on FLAIR MRI; details on the
rocedures involved have been described previously ( Firbank et al.,
003 ; Smart et al., 2011 ). All lesion maps from both baseline and
ollow-up visits were reviewed by a single experienced rater (A.L.)
hile blinded to all clinical information. Lesion maps obtained from
he segmentation procedure were used as starting points for manual
MH delineation. Baseline and follow-up FLAIR images were evaluated
ide by side during delineation to ensure consistency. WMH volumes
ere normalised by total intracranial volume to account for individual
ifferences in head size. To generate a descriptive voxelwise map
epresenting the spatial topography of WMH occurrence in our sample,
e normalised the binarized lesion maps to the MNI152 template using
he forward transformations from T1-MPRAGE to MNI152 space. Next,
he normalised lesion maps were concatenated using fslmaths . A mean
mage was created to represent the lesion probability map, in which the
ntensity of each voxel represents the likelihood of WMH occurrence
cross our sample. 
.5. Statistical analyses 
A summary of the key imaging outcomes is illustrated in Fig. 1 . To
haracterise brain imaging changes in relation to EYO, we used all avail-
ble longitudinal datasets for all participants. Demographic variables
ere compared between the APOE- 𝜀 4 groups using t -tests, Wilcoxon
ank sum tests, chi-square tests where appropriate. To increase robust-
ess of our correlations, EYO was transformed with the inverse nor-
al transformation due its skewed distribution, increasing the robust-
ess of correlations ( Miller et al., 2016 ). Voxelwise associations of EYO
ith imaging changes were investigated using the longitudinal Sand-
ich Estimator (SwE) toolbox ( http://www.nisox.org/Software/SwE )
 Guillaume et al., 2013 ). This marginal model describes expected vari-
bility as a function of predictors in a design matrix, while addition-
lly accounting for correlations due to repeated measurements and un-
xplained variations across individuals. The main models featured the
ain effects of EYO as well as its interactions with time (i.e. centred
ithin-subject age of participant). The latter metric allowed us to assess
hether a hypothetical proximity to dementia may have an accelerating
ffect of imaging changes over time, while the main effect of EYO indi-
ates whether a hypothetical proximity to dementia is related to imaging
ifferences across the sample, independent of other covariates. The co-
ariates included are (i) the demeaned mean age of a subject over both
ime points, (ii) the demeaned quadratic term of age to account for po-
ential non-linear age associations ( Kodiweera et al., 2016 ; Salami et al.,
012 ), (iii) sex, (iv) demeaned years of formal education and time. The
emeaned average WMH volume and its interaction with time were in-
luded as additional covariates in all DTI analyses to ensure that white
atter changes are not confounded by small vessel disease. In addition,
e examined both potential moderating and interactive effects of APOE-
 4 by modelling the main effects of APOE- 𝜀 4 and its interactions with
YO and time into the SwE models. Non-parametric statistical inference
as based on the Wild Bootstrap procedure ( Guillaume et al., 2015 ), and
orrections for multiple comparisons were performed with Threshold-
ree Cluster Enhancement (TFCE) and Family-Wise Error Rate (TFCE
 FWER < 0.05) ( Smith and Nichols, 2009 ). To report the coordinates
f significant clusters in standard MNI152 space, the mean FA of the
roup-specific template was affine registered to the MNI152 atlas using
LIRT and visually inspected. The affine transformation was then ap-
lied onto the statistical maps for anatomical localisations in MNI152
pace. To eliminate noise due to averaging and normalization, signifi-
ant clusters with < 50 voxels were excluded from the table of results.
on-voxelwise analyses of global FA, MD, RD, mean grey matter perfu-
ion, and mean cortical thickness were performed using Linear Mixed
ffect models (LME), implemented with the lmer function of the lme4
E. Mak, M.-E. Dounavi, A. Low et al. NeuroImage 229 (2021) 117749 
Fig. 1. Multi-modal neuroimaging outcome measures at both baseline and follow-up. Global FA, MD and RD were estimated using DTI-TK after generating a 
group-specific template that was unbiased to both time-points. T1-MPRAGE datasets were processed using Freesurfer for the segmentations of cortical thickness 
and hippocampus. ASL data were processed using FSL-BASIL, co-registered to the T1-MPRAGE, and visually inspected by 2 independent operators for errors in 
alignment. Grey matter perfusion was quantified following PVC of the CBF maps using the grey matter mask. WMHs were segmented from FLAIR data. Abbreviations: 
FA = Fractional Anisotropy, MD = Mean Diffusivity, RD = Radial diffusivity, DTI-TK = Diffusion Tensor Imaging Toolkit, AD = Alzheimer’s disease, ROI = Regions 

































Participant characteristics of subjects with diffusion weighted imaging 
datasets. 
APOE- 𝜀 4 − ( N = 42) APOE- 𝜀 4 + ( N = 37) P -value 
Age (years) 
Mean (SD) 53.4 (4.34) 51.8 (4.83) 0.086 
Median [Min, Max] 54.0 [41.0, 60.0] 52.0 [40.0, 60.0] 
Gender 
Female 31 (73.8%) 27 (73.0%) 0.99 
Male 11 (26.2%) 10 (27.0%) 
Education (years) 
Mean (SD) 15.7 (2.92) 15.7 (3.12) 0.561 
Median [Min, Max] 16.0 [11.0, 22.0] 17.0 [11.0, 21.0] 
ACE-III 
Mean (SD) 94.3 (4.73) 95.1 (3.93) 0.644 
Median [Min, Max] 95.0 [80.0, 100] 97.0 [82.0, 100] 
Missing 2 (4.8%) 0 (0%) 
ACE-III Memory 
Mean (SD) 24.6 (2.07) 24.8 (1.91) 0.974 
Median [Min, Max] 26.0 [18.0, 26.0] 25.0 [18.0, 26.0] 
Missing 2 (4.8%) 0 (0%) 
Time interval (years) 
Mean (SD) 2.00 (0.122) 2.01 (0.131) 0.957 
Median [Min, Max] 2.00 [1.72, 2.32] 1.98 [1.86, 2.46] 
EYO (years) 
Mean (SD) 24.6 (6.73) 23.5 (7.86) 0.345 
Median [Min, Max] 26.0 [4.00, 33.0] 25.0 [-3.00, 38.0] 
Abbreviations: ACE-III = Addenbrooke’s Cognitive Examination, EYO = Esti- 







c  ackage in R ( Bates et al., 2015 ). Consistent with our SwE models, the
ME models included a random intercept for each subject, and fixed
ffects of demeaned averaged age, demeaned quadratic age, sex, de-
eaned years of education and time (i.e. the demeaned within-subject
ge). WMH volumes were also included as additional covariates in our
nalyses on FA, MD and RD. 
As the EYO was derived based on the participant’s age, both mea-
ures were expected to be correlated ( r = − 0.3, p < 0.01; Supplemen-
ary Fig. 2). We also took extra caution to verify the absence of mul-
icollinearity in our models by calculating variance inflation factors
VIF) using the CAR package ( Fox and Monette, 1992 ; Fox and Weis-
erg, 2019 ). Finally, two sets of sensitivity analyses were conducted
o examine the robustness of the significant EYO associations against
hronological age. First, we repeated all significant LME and SwE mod-
ls while substituting the EYO variable with age. Secondly, to compare
he relative contributions of age, EYO and APOE- 𝜀 4 status on imag-
ng changes, we conducted group comparisons of imaging data between
edian-split age groups, median-split EYO groups, and APOE- 𝜀 4 status
sing ANCOVA. 
.6. Data availability 
Data will be made available upon reasonable requests and
or non-commercial reasons. The statistical maps, group templates
nd other relevant files are available to view on Neurovault
 https://identifiers.org/neurovault.collection:9099 ). 
. Results 
.1. Sample characteristics 
Demographic details about the sample with diffusion imaging
atasets are summarised in Table 1 . The EYO ranged from 38 years be-
ore the parental onset to − 3 years after onset. There were no signifi-
ant differences with regards to age, gender, education years or ACER
etween the APOE- 𝜀 4 carriers and non-carriers. 4 .2. Reliability of imaging data across time 
The sjstats package in R was used to calculate the intra class coef-
cients. ICC was calculated as the proportion of between-subject vari-
nce to total variance. The dependent variable for these models was the
lobal imaging measurement for each subject on two separate visits,
xed effects included the average age and time. Subject-specific inter-
ept was included as a random effect. Across all imaging measurements,
E. Mak, M.-E. Dounavi, A. Low et al. NeuroImage 229 (2021) 117749 
Fig. 2. Linear mixed effect modelling of global white matter microstructure in relation to EYO. Lower FA, and higher MD and RD values were associated with 
nearer proximity to hypothetical age of onset of dementia in FH + , after adjusting for averaged age, age 2 , gender, education years, averaged WMH volume, APOE- 𝜀 4 














































































y  CC was moderate to excellent [Mean cortical thickness: 0.87, FA: 0.73,
D: 0.74; RD: 0.74; ASL: 0.55]. 
.3. Grey matter atrophy 
There were no significant main effects of EYO on regional cortical
hickness and hippocampal volumes that survived false discovery rate
orrection for multiple comparisons. No regions showed a significant
nteraction between EYO × APOE4 status, or three-way interactions be-
ween EYO × Time × APOE4 status after false discovery rate correction
or multiple comparisons. 
.4. White matter microstructural changes 
The association between white mater changes and EYO are illus-
rated in Fig. 2 . There were no significant effects of APOE- 𝜀 4 status on
hite matter changes in terms of FA ( T = − 1.13, p = 0.26), MD ( T = 1.11,
 = 0.27) or RD ( T = 1.16, p = 0.25). LME models showed significant
ain effects of EYO on FA ( T = 2.58, p = 0.01), MD ( T = − 2.55, p = 0.01)
nd RD ( T = − 2.66, p = 0.01). There were no significant interactions be-
ween time and EYO ( T = − 1.12–1.43, p = 0.16–0.43). Voxelwise SwE
evealed widespread and significant main effects of EYO on FA, MD,
nd RD maps, after adjusting for averaged age, age 2 , gender, educa-
ion years, averaged white matter hyperintensity volume, APOE- 𝜀 4 sta-
us, and within-subject age (TFCE FWER p < 0.05). The EYO-associated
hite matter changes were predominantly found in the forceps minor
f the corpus callosum, inferior longitudinal fasciculi, superior longitu-
inal fasciculi, cingulum bundles, anterior thalamic radiation, inferior
ronto-occipital fasciculus, uncinate fasciculus (see Supplementary Ta-
le 3 for MNI152 coordinates of peak clusters). 
.5. White matter hyperintensities 
We illustrated the baseline WMH incidence, voxel-wise, across our
ample and revealed the expected spatial distribution of WMHs in nor-
al ageing ( Fig. 4 ). The highest probabilities of WMH were concentrated
round the periventricular areas and in deep white matter regions. There
ere no significant main effects of EYO ( T = − 0.74, p = 0.46) or EYO −
ime interactions ( T = − 1.06, p = 0.29) on WMH volumes. 
.6. Cerebral perfusion 
LME and SwE voxel-wise analyses revealed a significant interac-
ion of EYO with APOE- 𝜀 4 on grey matter perfusion (LME: T = − 2.87;
 = 0.01; SwE: TFCE FWER p < 0.05) such that APOE- 𝜀 4 carriers showed5 ncreased perfusion with nearer proximity to onset while APOE- 𝜀 4 non-
arriers did not ( Fig. 5 ). The difference in effects between APOE- 𝜀 4 car-
iers and non-carriers was qualified by a significant interaction term
LME: T = − 2.87; p = 0.01). Simple slope analyses and slope differ-
nce tests further confirmed a significant difference in the relation-
hip between EYO and ASL for the APOE- 𝜀 4 carriers and non-carriers,
uch that a significant association was found only amongst the APOE-
 4 carriers (Slope analysis: T = − 3.27; p < 0.01) and not for the non-
arriers (Slope analysis: T = 0.74; p = 0.462). Similarly, SwE voxel-
ise analyses revealed that the EYO × APOE- 𝜀 4 interaction was lo-
alised within temporo-parietal regions, such as the hippocampus, pre-
uneus/posterior cingulate cortices (TFCE FWER p < 0.05; see Supple-
entary Table 4 for MNI152 coordinates of peak clusters). There were
o significant three-way interactions between EYO, APOE- 𝜀 4 and time.
.7. Cross-modal relationships between ASL and DTI data 
Scatter plots of the relationships between grey matter perfusion and
WI metrics are shown in Fig. 6 . Post-hoc robust linear regressions in-
icated a significant negative correlation of FA ( T = − 2.95, p < 0.01)
nd positive correlations of MD ( T = 2.29, p = 0.03), and RD ( T = 2.66,
 = 0.01) with grey matter perfusion after adjusting for age, age 2 , gen-
er, education years, APOE- 𝜀 4 status, and WMH volumes. 
.8. Sensitivity analyses 
.8.1. Substituting EYO with age 
Given that age is correlated with EYO, we performed two sets of sen-
itivity analyses to evaluate the age-independence of the EYO results.
irst, the EYO term was substituted by the chronological age of the par-
icipant. These analyses are informative in terms of showing whether
he spatial extent of proximity-related white matter changes could be
ecapitulated from the participant’s age itself. First, age was not sig-
ificantly correlated with global mean FA ( T = − 1.88, p = 0.06), MD
 T = 1.31, p = 0.19) or RD ( T = 1.64, p = 0.11). Akaike Information
riteria analysis also indicated that including EYO resulted in a better
odel fit compared to a reduced model with age alone ( p = 0.007). Sec-
nd, in our voxelwise SwE models without the EYO term, older age was
nly associated with lower FA but not MD or RD (TFCE FWER p < 0.05).
he spatial extent of the age-FA associations was markedly smaller to
hat of the EYO (Dice volume overlap = 17.4%). The voxels that are
nique to either EYO, age, or overlapping effects are illustrated in Fig. 7 ,
howing that EYO is sensitive to microstructural changes over and be-
ond that of normal ageing. Similarly, in contrast to EYO, there was no
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Fig. 3. Sandwich estimator voxel-wise modelling of white 
matter microstructural changes in relation to EYO. Widespread 
extent of decreased FA, increased MD and RD were associ- 
ated with nearer proximity to hypothetical age of onset of de- 
mentia in FH + . Images are shown in radiological convention. 
Abbreviations: EYO = Estimated years to onset of dementia, 
FA = Fractional anisotropy, MD = Mean diffusivity, RD = Ra- 
dial diffusivity; TFCE = Threshold Free Cluster Enhancement, 















































d  ignificant interaction between age and APOE- 𝜀 4 status on mean grey
atter perfusion ( T = 0.46, p = 0.65). 
.8.2. Group comparisons of white matter across binarized subgroups 
We also attempted to disentangle the contributions of ageing, APOE-
 4 and EYO through a series of group comparisons ( Figure 8 ). The de-
endent variable was the imaging metric at baseline (i.e. FA). The cate-
orical covariates are age groups (Age ≥ 53 and Age < 53), APOE4 (Car-
iers and Non-Carriers), and EYO proximity groups (EYO ≥ 25 and EYO
 25). WMH volumes were also included to account for white matter
lterations due to small vessel diseases. This parsimonious stratification
f the sample enabled a comparison of the relative impact of each risk
actor on imaging changes. ANOVA indicated a significant main effect
hat was exclusive to EYO ( F = 6.52, p = 0.01). Furthermore, the ef-
ect size was the largest for EYO (Cohen ƒ = 0.3) relative to age (Cohen
= 0.06) and APOE- 𝜀 4 (Cohen ƒ = 0.09). The predominant effect of EYO
as also evident in MD and RD analyses. 
. Discussion 
Our study revealed an assortment of brain changes as cognitively
ormal FH + individuals approach their expected onset of dementia in
idlife. A shorter hypothetical proximity to dementia was associated
ith widespread white matter disruption ( ↓ FA ↑ MD ↑ RD), in the ab-
ence of grey matter atrophy. In addition, Moreover, our data showed6 hat hyperperfusion with shorter EYO was strongly predicated on the
resence of APOE- 𝜀 4 status. 
We did not find a robust effect of EYO on regional grey matter
trophy. This finding was not entirely unexpected, as cortical atro-
hy detected on MRI is widely believed to represent the terminal end-
roduct of neuronal loss, cell shrinkage, reductions in dendritic extent
nd synaptic loss ( McEwen, 1997 ). In contrast, extensive white matter
eficits were revealed as FH + individuals approached their estimated
ge of onset, involving major white matter bundles that are character-
stically compromised in mild cognitive impairment and AD ( Acosta-
abronero et al., 2010 ). Cross-sectional studies in late-onset AD and
amilial AD have demonstrated preferential vulnerability of the corpus
allosum, the superior and inferior longitudinal fasciculus, and cingu-
um bundles of the limbic projections, and our findings extend those
eports by documenting a similar profile of white matter degeneration
n a cognitively normal cohort of midlife adults. To the extent that EYO
s a valid stage marker of preclinical disease progression, it is conceiv-
ble that the pattern of white matter deficits in our data may reflect
ncipient neuropathologies (i.e. amyloid or early build-up of neurofib-
illary tau tangles). While the EYO correlations preclude causal interpre-
ations, our hypothesis is aligned with a recent study that included both
nte-mortem DTI and histological analyses in cognitively normal sub-
ects ( Kantarci et al., 2017 ). In that study, Kantarci et al., demonstrated
ssociations of temporo-parietal white matter tracts with amyloid bur-
en and tau accumulation ( Kantarci et al., 2017 ). Despite the lack of a
E. Mak, M.-E. Dounavi, A. Low et al. NeuroImage 229 (2021) 117749 
Fig. 4. Frequency maps of WMH distribution in our sample. Axial views demonstrate the mean pattern of WMH in our sample, overlaid on the T1-MNI152 template. 
The percentage of lesion probability is indicated by the colour bar. Abbreviation: WMH = White matter hyperintensities. 
Fig. 5. Associations of EYO with cerebral perfusion changes. A: After adjusting for averaged age, age 2 , gender, education years, and time, there was a significant EYO 
× APOE- 𝜀 4 interaction, indicating a pattern of hyperperfusion as APOE- 𝜀 4 carriers approached the hypothetical age of onset of dementia. 95% confidence intervals 
are illustrated by the blue and red boundaries in non-carriers and APOE- 𝜀 4 carriers respectively. B: SwE voxel-wise modelling of EYO x APOE- 𝜀 4 interactions on 
cerebral perfusion. Images are shown in radiological convention. Abbreviation: EYO = Estimated years to onset of dementia; FH + = Individuals with a family history 


















e  rior finding in the FH + literature, our findings are corroborated by re-
ent data from the Dominantly Inherited Alzheimer’s Network (DIAN)
roject, which found elevated MD with shorter EYO ( Caballero et al.,
018 ). Interestingly, there were pronounced EYO-related changes in the
enu of the corpus callosum, coinciding with the striking convergence
f proximity-related FA, MD, and RD changes in our sample ( Fig. 3 ). 
In contrast to the anticipated trajectory of ↓ FA ↑ MD ↑ RD on white
atter tracts, a shorter EYO was accompanied by increased perfusion
articularly amongst APOE- 𝜀 4 carriers. Hyperperfused regions encom-7 assed the temporo-parietal regions (i.e. precuneus, posterior cingulate,
edial temporal regions and hippocampus). At first glance, these re-
ults may appear to contradict the wealth of evidence showing ~40%
lobal deficit of CBF in people with AD in the same aforementioned
egions ( Alsop et al., 2010 ; Wierenga et al., 2014 ). However, our data
re also aligned with other reports of hyperperfusion amongst APOE- 𝜀 4
arriers ( Bangen et al., 2012 ; Wierenga et al., 2013 ): increased glucose
ptake from FDG-PET studies have been found in FAD mutation carri-
rs as early as 25 years before expected onset ( Benzinger et al., 2013 )
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Fig. 6. Scatter plots of the associations between grey matter perfusion and global white matter indices. 95% confidence intervals are illustrated by the green and 
purple boundaries in non-carriers and APOE- 𝜀 4 carriers respectively. Abbreviation: FH + = Individuals with a family history of dementia; FA = Fractional anisotropy, 
MD = Mean diffusivity, RD = Radial diffusivity. 
Fig. 7. Comparing the spatial extent of FA changes with age and EYO. Binarised maps of the TFCE corrected maps are shown. Older age correlated with FA 
reductions primarily in the corpus callosum, whereas EYO was associated with a broader extent of FA reductions that encompassed the corpus callosum, inferior and 
superior longitudinal fasciculus, cingulum, inferior fronto-occipital fasciculus and corticospinal tract. Abbreviations: EYO = Estimated years to onset of dementia, 




















f  hile Alsop et al. have reported hippocampal hyper-perfusion in cases
ith AD ( Alsop et al., 2008 ). Taken together, our current perfusion data
re consistent with a model of disease progression in the asymptomatic
eriod of dementia, in which APOE- 𝜀 4 carriers display elevated cere-
ral perfusion very early during the presymptomatic phase as a possible
ttempt to maintain an adequate blood supply at rest. Hyperperfusion
ould also be a response to neuroinflammation ( Alsop et al., 2008 ), al-
erations in the capillary transit time ( Østergaard et al., 2013 ) or as-
ociated with amyloid accumulation ( Fazlollahi et al., 2020 ). Another
ossible explanation is that the higher ASL signal is driven by delayed8 ntravascular signal. However, our subjects were all healthy participants
ence we do not expect large differences in the arterial transit time. The
nversion time used in our protocol is also aligned with previous recom-
endations ( Alsop et al., 2015 ). In a study by Wierenga et al. (2013 ) the
nteraction of age and APOE- 𝜀 4 was investigated in relation to CBF and
t was found that young APOE- 𝜀 4 (mean age: 24) demonstrated hyper-
erfusion, whereas older APOE- 𝜀 4 carriers (mean age: 75) demonstrated
ypo-perfusion compared to non-carriers. Some plausible explanations
or the observed associations include the (a) uncoupling of the flow
rom metabolic demands in young adults, in turn leading to cerebrovas-
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Fig. 8. Proximity to dementia is the predominant contributor to white matter changes compared to age and APOE- 𝜀 4 status. FH + individuals who are less than 25 
years to estimated onset showed significantly reduced white matter FA compared to FH + individuals who are ≥ 25 years away from estimated onset. EYO group had 




































outcomes. ular dysregulation, (b) a differential effect of APOE- 𝜀 4 on neurovas-
ular function in aging, (c) and hypo-perfusion as a result of amyloid
ccumulation or even underlying structural alterations in the vascula-
ure in older carriers. These hypotheses are especially pertinent to this
tudy, considering the intermediate mean age of our cohort relative to
he aforementioned age groups ( Wierenga et al., 2013 ). Future studies
ith additional measurements of cerebral hemodynamics using arterial
ransit time sensitive ASL acquisitions or diffusion weighted ASL may be
ell-suited to reveal further insights into the hemodynamic changes and
dentify the inevitable inflection point associated with the emergence of
he AD-signature pattern of hypoperfusion. 
A key strength of the present study is the integration of multi-modal
R imaging, enabling several inferences regarding the evolution of dis-
inct pathological mechanisms along the preclinical spectrum. First,
he coupling of EYO with DTI instead of cortical thickness provides
urther support to the argument that microstructural changes – typi-
ally not visible on T1-MPRAGE – predate macroscale neurodegener-
tion/brain atrophy, and thus could predict subsequent cognitive de-9 line with greater sensitivity ( Kantarci et al., 2005 ; Müller et al., 2005 ;
ingman et al., 2007 ; Weston et al., 2015 ). Secondly, against the back-
rop of widespread white matter degeneration, it is tempting to specu-
ate that elevated perfusion may reflect the harnessing of greater neural
esources to help circumvent the deteriorating efficiency of cognitive
etworks. There is some tangential support for this hypothesis from a
ecent study showing a paradoxical relationship between elevated cere-
ral perfusion and increased amyloid burden in a cognitively normal
lderly cohort ( Fazlollahi et al., 2020 ). Likewise, a compensatory hy-
othesis would have the corollary that elevated cerebral perfusion is
ccompanied by microstructural impairments ( ↓ FA ↑ MD ↑ RD), as was
onfirmed in our post-hoc cross-modal associations between DTI and
SL. Interestingly, a recent study found the inverse relationship in pa-
ients with chronic traumatic brain injury (TBI, but not in those with
ess remote TBI ( Clark et al., 2017 ). Taken together, these findings pro-
ide preliminary evidence for a dynamic association between CBF and
hite matter integrity that may exert deleterious effects on cognitive






















































































































Valid interpretations of the EYO × imaging associations are critically
ependent on the removal of age-related confounds. As expected, there
as a modest correlation of R = − 0.3 in our study (Supplementary Fig.
). While the narrow age range of our study may reduce the risk of
purious correlations between EYO and imaging findings, we undertook
everal analyses to ensure the robustness of the EYO findings against
ge. Firstly, our EYO findings remained significant after correcting for
oth the linear and quadratic terms of age in all analyses. Secondly, to
ssess the age-independence of the associations between EYO and imag-
ng changes, we repeated our analyses by using age itself as the predictor
f imaging changes in lieu of EYO. There were focal age-associated re-
uctions in FA within the corpus callosum, in keeping with previous
tudies ( Bennett et al., 2010 ; Salami et al., 2012 ). In contrast, the ex-
ensive associations of EYO with white matter deficits ( ↓ FA ↑ MD ↑
D) are indicative of other mechanisms that are distinct from normal
geing. Indeed, future studies investigating CSF or PET biomarkers of
 
18 F]-AV1451 and [ 11 C]-PiB in relation to EYO would be imperative to
elineate the pathological undercurrents of white matter dysfunction as
ndividuals approach dementia onset. 
Our findings should also be considered with several other caveats.
MHs may confound our interpretations of DTI findings. However,
ur cohort is one of the youngest in the prevailing literature, and
s such would be expected to have less cerebrovascular pathology
 Stefaniak et al., 2018 ). In addition, all DTI analyses were corrected for
MH volumes. The lack of associations between EYO and WMH could
lso be interpreted in the context of a previous study in FAD mutation
arriers, which found an association between shorter EYO and more se-
ere WMH only amongst individuals with autosomal dominant genetic
utations, whereas no such correlations were found amongst the non-
arriers ( Lee et al., 2016 ). Another limitation is that the utilised ASL
cquisition did not allow for quantification of arterial transit time and
he separation of arterial and tissue compartments. However, we do not
nticipate large variability in arterial transit time given the inversion
ime of 1.8 s in our ASL protocol. The dominant model for perfusion
uantification in ASL which was used in the present study, assumes in-
tantaneous water exchange between the capillary and tissue compart-
ents ( Buxton et al., 1998 ). In the case of altered water exchange rates,
tilization of a single-compartment model could potentially introduce
ias in CBF quantification. It is still unclear the water exchange rate dif-
ers between APOE4 carriers and non-carriers, especially during the pre-
linical stage of the disease. In a recent study by Montagne et al., cogni-
ively asymptomatic APOE4 carriers demonstrated a blood brain barrier
reakdown compared to APOE3 carriers, however the examined cohort
as more than 10 years older on average compared to the present study
 Montagne et al., 2020 ). Future studies using novel ASL sequences capa-
le of quantifying delays in the blood delivery to the tissue or changes in
he water exchange rate could reveal more insights about neurovascular
hanges associated with preclinical dementia and EYO ( Jezzard et al.,
018 ; Shao et al., 2019 ). Finally, despite a modest genetic influence on
he age of onset of AD ( Day et al., 2019 ), the EYO variable remains a
ypothetical stage marker of subclinical disease progression and its util-
ty for early diagnosis in sporadic dementia is still an open question. On
his note, 1 subject had a negative EYO (i.e., older than his/her parental
ge of dementia). However, repeating the analyses without this subject
id not influence our findings. 
. Conclusions 
Building upon previous work of proximity-related brain changes in
amilial AD mutation carriers, the plethora of findings in this study pro-
ide compelling evidence that the preclinical phase of sporadic demen-
ia is characterised by subtle microstructural and physiological cere-
ral abnormalities in the absence of grey matter atrophy. Crucially, we
emonstrated that these changes are not simply a reflection of normal
geing, highlighting the estimated temporal proximity to dementia as a
otential metric with valuable clinical relevance and prognostic utility.10 urther validation of the EYO in larger samples of cognitively normal
POE- 𝜀 4 carriers/FH + is warranted and will be performed as more sub-
ects in PREVENT-Dementia complete their follow-up assessments. 
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